![Addressing the yearly $53B problem for pharma companies using groundbreaking AI and ‘Patient- on-a-chip’ technology](https://industry.pharmafocusasia.com/slider/1719490827-addressing-the-yearly-01.png)
Ractigen Therapeutics a leader in small activating RNA therapies has received Rare Pediatric Disease Designation from the US Food and Drug Administration for its saRNA candidate RAG
IASO Biotechnology a company specializing in advanced cell therapy and antibody products has received approval from the National Medical Products Administration for its investigational new drug
Aforalls US subsidiary Milla Pharmaceuticals Inc has introduced its generic version of PrecedexDexmedetomidine Hydrochloride Injection in mcg per mL and mcg per mL formulated
Eisai Co Ltd and EcoNaviSta Inc have formed a strategic alliance to tackle dementia a significant challenge in Japans aging population Eisai a leader in dementia research and awareness and EcoNaviSta
Pfizer Inc has released positive topline results from the Phase AFFINE study which tested giroctocogene fitelparvovec a gene therapy for adults with moderately severe to severe hemophilia A
BeiGene Ltd a global oncology company has launched its flagship US facility at the Princeton West Innovation Campus in Hopewell NJ This advanced site features cuttingedge biologics
Macquarie University researchers have identified a gene therapy that could help treat the eye disease glaucoma with potential applications for other neurodegenerative conditions such as Alzheimers disease Glaucoma may result in irreversible blindness over to years if left untreated Like Alzheimers...
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that dosing has recently begun in an integrated Phase I
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology cardiovascular and metabolic
ObvioHealth a global digital clinical trials company announces a new strategic investment by Guardant Health Inc a leading precision oncology company offering liquid
BioThera Solutions Inc a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars today announced that the FDA has accepted the BLA for BAT a proposed
NanoViricides Inc a clinical stage global leader in broadspectrum antiviral nanomedicines today reminds the strong safety and effectiveness against coronaviruses demonstrated by its lead clinical drug candidate
Boston, MA, USA
jakarta barat, Indonesia
Jakarta Barat, Indonesia
Songdo Convensia, Incheon, South Korea
Songdo Convensia, Incheon, South Korea
Lisbon, Portugal
London, UK
President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Doctoral Research Scholar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Director of Strategic Initiatives, Biomonitoring Solutions at Merck
Department of Cell and Molecular Biology, Iladevi Cataract And IOL Research Centre
Department of Cell and Molecular Biology, Iladevi Cataract and IOL Research Centre
Department of Zoology, BMTC, Human Genetics, USSC, Gujarat University
Full Professor, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce
Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec, and INFN-Lecce
Researcher, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce
PhD Student, Omnics Research Group @ University of Salento, CNR-Nanotec and INFN-Lecce
Founder
Interpharm Consultancy has been providing advice about the UK generic market and consultancy services to generic manufacturers and distributorsThe liability of a drug substance to the metabolism is referred to as metabolic stability The liver uses CYPmediated metabolism to clear most orally administered drugs Metabolic stability data is essential for evaluating and optimising the human therapeutic dose for the drug In vitro systems obtained fromthe human liver such as microsomes and hepatocytes
AbstractInterventional clinical studies can provide the highest levels of evidence and generate significant results on specific investigational medicinal products or medical devices In order to have powerful studies attain unquestionable results and make significant discoveries the number of patients enrolled must be high Therefore multinational randomis
AbstractThis essay studies work in sociology and cognate fields regarding pharmaceutical marketing and its regulation In particular it considers how this literature contributes to a better understanding of the process of pharmaceuticalization defined as the translation or transformation of human conditions capabilities and capacities into opportuni
Stanford Medicine has discovered a novel tumourtargeting radiation therapy machine for cancer treatment
SummaryEvery business faces risk Broadly speaking the primary categories of business risk are Market Financial Execution and Regulatory Successful companies have developed a core competency in managing for these risks turning risk management into a sustainable competitive advantage For drug manufacturers recent trends have underscored the importance o
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster